DK0770876T3 - En screening-fremgangsmåde til at identificere ligander for målproteiner - Google Patents

En screening-fremgangsmåde til at identificere ligander for målproteiner

Info

Publication number
DK0770876T3
DK0770876T3 DK96610042T DK96610042T DK0770876T3 DK 0770876 T3 DK0770876 T3 DK 0770876T3 DK 96610042 T DK96610042 T DK 96610042T DK 96610042 T DK96610042 T DK 96610042T DK 0770876 T3 DK0770876 T3 DK 0770876T3
Authority
DK
Denmark
Prior art keywords
target proteins
target protein
ligands
screening method
identifying ligands
Prior art date
Application number
DK96610042T
Other languages
Danish (da)
English (en)
Inventor
Andrew Pakula
James Bowie
Original Assignee
Anadys Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anadys Pharmaceuticals Inc filed Critical Anadys Pharmaceuticals Inc
Application granted granted Critical
Publication of DK0770876T3 publication Critical patent/DK0770876T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK96610042T 1995-10-25 1996-10-17 En screening-fremgangsmåde til at identificere ligander for målproteiner DK0770876T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54788995A 1995-10-24 1995-10-24

Publications (1)

Publication Number Publication Date
DK0770876T3 true DK0770876T3 (da) 2001-08-06

Family

ID=24186560

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96610042T DK0770876T3 (da) 1995-10-25 1996-10-17 En screening-fremgangsmåde til at identificere ligander for målproteiner

Country Status (14)

Country Link
EP (1) EP0770876B1 (pt)
JP (1) JP2952848B2 (pt)
KR (1) KR0161256B1 (pt)
AT (1) ATE200579T1 (pt)
AU (1) AU698862B2 (pt)
BR (1) BR9604352A (pt)
CA (1) CA2184195C (pt)
DE (2) DE770876T1 (pt)
DK (1) DK0770876T3 (pt)
ES (1) ES2158269T3 (pt)
GR (1) GR3036138T3 (pt)
IL (1) IL119149A (pt)
MX (1) MX9604183A (pt)
PT (1) PT770876E (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6036920A (en) 1996-05-09 2000-03-14 3-Dimensional Pharmaceuticals, Inc. Microplate thermal shift assay apparatus for ligand development and multi-variable protein chemistry optimization
US6453246B1 (en) 1996-11-04 2002-09-17 3-Dimensional Pharmaceuticals, Inc. System, method, and computer program product for representing proximity data in a multi-dimensional space
WO1998020437A2 (en) 1996-11-04 1998-05-14 3-Dimensional Pharmaceuticals, Inc. System, method and computer program product for identifying chemical compounds having desired properties
US6571227B1 (en) 1996-11-04 2003-05-27 3-Dimensional Pharmaceuticals, Inc. Method, system and computer program product for non-linear mapping of multi-dimensional data
IL136046A0 (en) 1997-11-12 2001-05-20 Dimensional Pharm Inc Methods for classifying proteins
US6569631B1 (en) 1998-11-12 2003-05-27 3-Dimensional Pharmaceuticals, Inc. Microplate thermal shift assay for ligand development using 5-(4″dimethylaminophenyl)-2-(4′-phenyl)oxazole derivative fluorescent dyes
GB9904395D0 (en) * 1999-02-25 1999-04-21 Fluorescience Ltd Protein assay
US6972198B2 (en) * 1999-02-26 2005-12-06 Cyclacel, Ltd. Methods and compositions using protein binding partners
JP4493125B2 (ja) 1999-05-07 2010-06-30 独立行政法人理化学研究所 相互作用するタンパク質の検出方法
US6582907B1 (en) * 1999-12-09 2003-06-24 Pharmacia & Upjohn Company Use of fluorescence correlation spectroscopy to identify compounds that bind to target species under isothermal denaturing conditions
US6376180B1 (en) * 1999-12-09 2002-04-23 Pharmacia & Upjohn Company Methods of identifying compounds that bind to target species under isothermal denaturing conditions
US7416524B1 (en) 2000-02-18 2008-08-26 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. System, method and computer program product for fast and efficient searching of large chemical libraries
US6671627B2 (en) 2000-02-29 2003-12-30 3-D Pharmaceuticals, Inc. Method and computer program product for designing combinatorial arrays
WO2001071624A1 (en) 2000-03-22 2001-09-27 3-Dimensional Pharmaceuticals, Inc. System, method, and computer program product for representing object relationships in a multidimensional space
WO2001075790A2 (en) 2000-04-03 2001-10-11 3-Dimensional Pharmaceuticals, Inc. Method, system, and computer program product for representing object relationships in a multidimensional space
KR20010112840A (ko) * 2000-06-15 2001-12-22 김유삼 기능성 단백질의 패턴분석을 이용한 진단 시스템
WO2002061419A1 (en) 2001-01-29 2002-08-08 3-Dimensional Pharmaceuticals, Inc. Method, system, and computer program product for analyzing combinatorial libraries
DE60216487T2 (de) * 2001-09-03 2007-09-13 Kyowa Hakko Kogyo Co., Ltd. Verfahren zur bestimmung eines zielproteins eines arzneistoffs
EP1436620B1 (en) 2001-09-10 2014-04-23 Meso Scale Technologies, LLC Methods and apparatus for conducting multiple measurements on a sample
EP2124062A1 (en) 2005-08-12 2009-11-25 Astellas Pharma Inc. Method for identifying target protein of drug and method for screening therapeutic agent for diabetes using the target protein.
DE102006027259A1 (de) * 2006-06-09 2007-12-13 Protagen Ag Protein-Biochip zum differentiellen Screenen von Protein-Protein-Wechselwirkungen
WO2018152329A1 (en) 2017-02-15 2018-08-23 Ohio State Innovation Foundation Heteroaromatic electrophiles and methods of using thereof
CN114076826A (zh) * 2020-08-20 2022-02-22 中国科学院大连化学物理研究所 一种微球辅助的基于蛋白加热沉淀的药物靶蛋白筛选方法
GB202118173D0 (en) * 2021-12-15 2022-01-26 Medicines Discovery Catpult Ltd Protein stability assay

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5231755B2 (pt) * 1973-01-08 1977-08-17
US4859609A (en) * 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
EP0546084A4 (en) * 1990-08-17 1994-10-19 Univ Boston Proteases causing abnormal degradation of amyloid -g(b)-protein precursor
US5506097A (en) * 1990-08-24 1996-04-09 President And Fellows Of Harvard College Method for inhibiting β-protein enzymatic activity
WO1993014781A1 (en) * 1992-01-24 1993-08-05 The Regents Of The University Of California Novel peptides and method for altering the activity of allosteric proteins
CA2115900A1 (en) * 1993-02-22 1994-08-23 Gerald W. Becker Pharmaceutical screens and antibodies
US5585277A (en) * 1993-06-21 1996-12-17 Scriptgen Pharmaceuticals, Inc. Screening method for identifying ligands for target proteins
US6306829B1 (en) * 1995-12-08 2001-10-23 Hybridon, Inc. Modified VEGF oligonucleotides for treatment of skin disorders
CA2236339A1 (en) 1995-12-07 1997-06-12 Robert T. Sauer A fluorescence-based screening method for identifying ligands
US6036920A (en) * 1996-05-09 2000-03-14 3-Dimensional Pharmaceuticals, Inc. Microplate thermal shift assay apparatus for ligand development and multi-variable protein chemistry optimization
US8082993B2 (en) 2009-03-12 2011-12-27 Halliburton Energy Services, Inc. One trip gravel pack assembly

Also Published As

Publication number Publication date
DE69612457D1 (de) 2001-05-17
MX9604183A (es) 1998-04-30
EP0770876B1 (en) 2001-04-11
PT770876E (pt) 2001-09-28
KR0161256B1 (ko) 1999-03-30
CA2184195C (en) 2002-04-16
AU698862B2 (en) 1998-11-12
JP2952848B2 (ja) 1999-09-27
KR970022315A (ko) 1997-05-28
JPH09178746A (ja) 1997-07-11
DE69612457T2 (de) 2001-11-08
ES2158269T3 (es) 2001-09-01
IL119149A (en) 2002-03-10
IL119149A0 (en) 1996-11-14
ATE200579T1 (de) 2001-04-15
DE770876T1 (de) 1999-07-22
GR3036138T3 (en) 2001-09-28
BR9604352A (pt) 1998-06-16
CA2184195A1 (en) 1997-04-26
AU6429896A (en) 1997-05-01
EP0770876A1 (en) 1997-05-02

Similar Documents

Publication Publication Date Title
DK0770876T3 (da) En screening-fremgangsmåde til at identificere ligander for målproteiner
ATE376187T1 (de) Nachweis von erkrankungen der nieren und behandlung
DE69632447D1 (de) Analysator zur Analyse von Urinbestandteilen
DE69620903D1 (de) Nachweiss von nukleinsäuren durch bildung von template abhängigen produkt
DE69612017D1 (de) Emulsion zur robusten erfassung von gasen
DE69638248D1 (de) Nachweis von DNS-Sequenz Variationen
DE69422351D1 (de) Teilchenanalyse von gekerbten Scheiben
DE3887168D1 (de) Verfahren zur quantitativen analyse von mineralien.
ATE148923T1 (de) Funktioneller test und reagenz zur bestimmung von fibrinogen
DE3765138D1 (de) Mehrschichtiges element zur quantitativen analyse von immunoreagenzien.
DE68929334D1 (de) Verfahren zumm Assay von Endotoxin-Konzentration
DE69622978D1 (de) Analysator zur Analyse von Urinbestandteilen
ATE397215T1 (de) Entstörung von immunoassays durch substanzen, die aus den framework-regionen von antikörpern abgeleitet sind
DE69312185D1 (de) Chromatographischer Sandwichtest zur Bestimmung von spezifischen Antikörpern und Vorrichtung hierfür
DE59508137D1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
DE3889279D1 (de) Diagnostisches Mittel und Verfahren zur Bestimmung von Apolipoprotein B.
DK173884D0 (da) Fremgangsmaade til kvantitativ bestemmelse af haemoglobinkoncentrationen i en biologisk proeve
DK0445626T3 (da) Funktionel test til bestemmelse af protein S-aktivitet.
DE69007155D1 (de) Automatisierte Schnittentwicklungsanalyse von mehrfachen Proben.
DE59510146D1 (de) Antikörper für den Nachweis von Salmonellen
DE69022795D1 (de) Nachweis eines Antikörpers und dessen Immunglobulin-Klasse.
RU94021664A (ru) Способ идентификации и количественного определения вредных побочных продуктов сульфирования методом ионной хроматографии
FI913417A0 (fi) Anordning vid vattensaeng.
DE59008687D1 (de) Verfahren zur selektiven komplexometrischen quantitativen Bestimmung von N-(Phosphonomethyl)-glycin-(glifosat(R)) und Derivat davon.
FI893333A0 (fi) Menetelmä ja reagenssi vasta-aineiden määrittämiseksi